Argireline

Argireline

Quick Facts

  • Full Name: Argireline (Acetyl Hexapeptide-3 / Acetyl Hexapeptide-8)
  • Aliases: Acetyl Hexapeptide-3, AH3, Leuphasyl (complementary peptide), "Topical Botox"
  • Category: Skin Health / Anti-Aging / Topical Cosmetic Peptide / Expression Lines
  • Sequence: Acetyl-Glu-Glu-Met-Gln-Arg-Arg-NH2 (hexapeptide; N-acetylated)
  • Molecular Weight: ~889 Da
  • Administration: Topical only
  • Typical Concentration: 5โ€“10% in finished formulation
  • Status: Cosmetic ingredient (INCI listed); widely commercially available
  • WADA Status: Not applicable

What It Does

Argireline is the most widely used "Botox-like" topical peptide. It works by competitively inhibiting the SNARE complex โ€” the same molecular machinery that Botox (botulinum toxin) disrupts โ€” thereby reducing the release of neurotransmitters at the neuromuscular junction of facial muscles. The result is a reduction in muscle contraction intensity beneath expression lines (crow's feet, forehead, glabellar lines) without paralysis. Effects are reversible, dose-dependent, and require continuous use. At 10%, clinical studies show ~27โ€“30% reduction in wrinkle depth.

Mechanism of Action

  1. SNARE complex interference: Argireline's sequence mimics the N-terminal domain of SNAP-25 (synaptosomal-associated protein 25) โ†’ competitively inhibits the SNAP-25/VAMP/Syntaxin SNARE complex โ†’ reduces vesicular acetylcholine release at neuromuscular junctions
  2. Reduced muscle contraction: Less acetylcholine release โ†’ lower facial muscle contraction amplitude โ†’ reduced dynamic wrinkle formation
  3. Neurotransmitter catecholamine reduction: Also reduces catecholamine release in skin โ†’ secondary relaxation effects
  4. Collagen synthesis support: Secondary effect โ€” reduces mechanical stress on dermal ECM โ†’ slower collagen degradation from repetitive movement

Dosing Protocols

Topical Formulation

  • Concentration: 5โ€“10% in finished serum or cream
  • Application: Apply to targeted areas (forehead, crow's feet, glabella, perioral) 1โ€“2x daily
  • Onset: 2โ€“4 weeks for visible softening of expression lines
  • Best in: Leave-on serums, eye creams, targeted treatment products
  • Penetration enhancers: DMSO or neopentyl glycol diheptanoate improve delivery
  • Source: The Peptides Bible topical section; Lipotec technical data

High-Performance Formulation

  • Combine with Leuphasyl (5% Leuphasyl + 5% Argireline) for synergistic SNARE disruption
  • Add Syn-ake for complementary acetylcholine receptor blockade

Related Peptides

  • SNAP-8 โ€” Elongated version of Argireline (Acetyl Octapeptide-3, 8 amino acids vs. Argireline's 6). Same SNARE complex inhibition mechanism with potentially improved binding affinity due to additional C-terminal Ala-Asp residues.

Stacks Well With

  • SNAP-8 – elongated Argireline; can be combined but mechanism overlap means diminishing returns
  • Syn-ake – complementary mechanism (nicotinic receptor antagonism); potent anti-wrinkle combination
  • Matrixyl – SNARE inhibition + collagen stimulation for comprehensive anti-aging
  • GHK-Cu – anti-inflammatory and remodeling support alongside muscle relaxation
  • GHK (Tripeptide-1) – free copper-free GHK for elastin and collagen synergy

Use Cases

  • Expression Lines (crow's feet, forehead lines, glabellar "11s", lip lines)
  • Dynamic Wrinkles reduction (movement-caused)
  • Anti-Aging Skincare (daily preventative and corrective)
  • Botox Alternative (non-invasive option)
  • Eye Area rejuvenation

Contraindications & Safety

  • Very well-tolerated; extensive safety data as cosmetic ingredient
  • Sensitive skin โ€” rare mild irritation; patch test recommended at 10%
  • Pregnancy โ€” topical peptides generally considered safe; consult dermatologist
  • No systemic absorption at cosmetic concentrations โ€” topical Botox-like effects are local and reversible
  • Effects cease within weeks of discontinuation (reversible, unlike Botox)

Storage

  • Bulk liquid/powder: 2โ€“8ยฐC; protect from light and heat
  • Finished product: Room temperature in opaque packaging; per manufacturer specification
  • Stability: 18โ€“24 months in stable formulation at appropriate pH (4.5โ€“7.0)

PubMed Research

Research links will be added after PubMed search

Sources

  • The Peptides Bible – Topical cosmetic peptides
  • Lipotec โ€” original Argireline research and technical data
  • Blanes-Mira et al. โ€” SNARE inhibition and wrinkle reduction clinical data

#skin-health #anti-aging #expression-lines #SNARE #topical #cosmetic #Argireline #botox-like #wrinkle-reduction